Direct parametric inference for the cumulative incidence function

Journal of the Royal Statistical Society. Series C: Applied Statistics

Volumn 55, Issue 2, 2006, Pages 187-200

  Jeong, Jong Hyeon ^a   Fine, Jason ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Breast cancer; Clinical trial; Competing risks; Cumulative incidence; Cure model; Improper distribution

Indexed keywords

EID: 33644634798     PISSN: 00359254     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-9876.2006.00532.x     Document Type: Article

References (24)

1. Aalen, O. O. (1978) Nonparametric inference for a family of counting processes. Ann. Statist., 6, 701-726.
2. Akaike, H. (1974) A new look at statistical model identification. IEEE Trans. Autom. Control, 19, 716-722.
3. Benichou, J. and Gail, M. H. (1990) Estimates of absolute cause-specific risk in cohort studies. Biometrics, 46, 813-826.
4. Boag, J. W. (1949) Maximum likelihood estimates of the proportion of patients cured by cancer therapy. J. R. Statist. Soc. B, 11, 15-44.
5. Bryant, J. and Dignam, J. J. (2004) Semiparametric models for cumulative incidence functions. Biometrics, 60, 182-190.
6. Fine, J. P. (2001) Regression modelling of competing crude failure probabilities. Biostatistics, 2, 85-97.
7. Fine, J. P. and Gray, R. J. (1999) A proportional hazards model for the subdistribution of a competing risk. J. Am. Statist. Ass., 94, 496-509.
8. Fisher, B., Jeong, J. H., Anderson, S., Bryant, I, Fisher, E. R. and Wolmark, N. (2002) Twenty-five year findings from a randomized clinical trial comparing radical mastectomy with total mastectomy and with total mastectomy followed by radiation therapy. New Engl. J. Med., 347, 567-575.
9. Gaynor, J. J., Feuer, E. I, Tan, C. C., Wu, D. H., Little, C. R., Strauss, D. J., Clarkson, B. D. and Brennan, M. F. (1993) On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J. Am. Statist. Ass., 88, 400-409.
10. Gompertz, B. (1825) On the nature of the function expressive of the law of human mortality, and on the new mode of determining the value of life contingencies. Phil Trans. R. Soc. Lond. A, 115, 513-580.
11. Kalbfleisch, J. D. and Prentice, R. L. (1980) The Statistical Analysis of Failure Time Data. New York: Wiley.
12. Kaplan, E. L. and Meier, P. (1958) Nonparametric estimator from incomplete observations. J. Am. Statist. Ass., 53, 457-481.
13. Karrison, T. G., Ferguson, D. J. and Meier, P. (1999) Dormancy of mammary carcinoma after mastectomy. J. Natn. Cancer Inst., 191, 80-85.
14. Korn, E. L. and Dorey, F. J. (1992) Applications of crude incidence curves. Statist. Med., 11, 813-829.
15. Larson, M. G. and Dinse, G. E. (1985) A mixture model for the regression analysis of competing risks data. Appl. Statist., 34, 201-211.
16. Lin, D. Y. (1997) Non-parametric inference for cumulative incidence functions in competing risks studies. Statist. Med., 16, 901-910.
17. Maller, R. A. and Zhou, X. (1996) Survival Analysis with Long-term Survivors. New York: Wiley.
18. Maller, R. A. and Zhou, X. (2002) Analysis of parametric models for competing risks. Statist. Sin., 12, 725-750.
19. Nelson, W. (1972) Theory and applications of hazard plotting for censored failure data. Technometrics, 14, 945-965.
20. Pepe, M. S. and Mori, M. (1993) Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Statist. Med., 12, 737-751.
21. Prentice, R. L., Kalbfleisch, J. D., Peterson, Jr, A. V., Flournoy, N., Farewell, V. T. and Breslow, N. E. (1978) The analysis of failure times in the presence of competing risks. Biometrics, 34, 541-554.
22. Recht, A., Gray, R., Davidson, N. E., Fowble, B. L., Solin, L. J., Cummings, F. J., Falkson, G., Falkson, H. C., Taylor, S. G. and Torney, D. C. (1999) Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without radiation: experience of the Eastern Cooperative Oncology Group. J. Clin. Oncol., 17, 1689-1700.
23. Taghian, A., Jeong, J. H., Mamounas, E., Anderson, S., Bryant, J., Deutsch, M. and Wolmark, N. (2004) Pattern of loco-regional failure in patients with breast cancer treated by mastectomy and chemotherapy (+/- tamoxifen) without radiation: results from five NSABP randomized trials. J. Clin. Oncol., 22, 4247-4254.
24. Tsiatis, A. A. (1978) An example of nonidentifiability in competing risks. Scand. Act. J., 235-239.